Investigation of Perioperative Antimicrobial Cefazolin in Excess of 100 mg/kg/day in Pediatric Patients Undergoing Spinal Fusion Surgery-Reference-Cited by-同舟云学术

Investigation of Perioperative Antimicrobial Cefazolin in Excess of 100 mg/kg/day in Pediatric Patients Undergoing Spinal Fusion Surgery

Published:2021-05-10 Issue:5 Volume:47 Page:234-238
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Jpn. J. Pharm. Health Care Sci.

Author:

Kurishima Akira¹,Shioda Tomoko¹,Sasaki Yasuhiro²,Isozaki Ryo¹,Jibiki Yukiko¹,Tajima Sachiko³,Ono Takashi⁴

Affiliation:

1. Department of Pharmacy, Japan Community Health Care Organization Tokyo Shinjuku Medical Center

2. Department of Pharmacy, Tama-Nambu Chiiki Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation

3. Department of Nursing, Japan Community Health Care Organization Tokyo Shinjuku Medical Center

4. Department of Orthopaedic Surgery, Japan Community Health Care Organization Tokyo Shinjuku Medical Center

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/jjphcs/47/5/47_234/_pdf

Reference12 articles.

1. 1）竹末芳生, 岸本裕充, 久保正二, 坂本春生, 鈴木　崇, 高橋佳子, 橋本昌樹, 保富宗城, 松下和彦, 三鴨廣繁, 山田浩司, 山本新吾, 柚木靖弘, 真弓俊彦, 岡　正朗, 北川雄光, 小西敏郎, 福島亮治, 尾原秀明, 小林美奈子, 武田　茂, 術後感染予防抗菌薬適正使用のための実践ガイドライン, 日本化学療法学会雑誌, 2016, 64, 153-232.

2. 2）Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA; American Society of Health-System Pharmacists; Infectious Disease Society of America; Surgical Infection Society; Society for Healthcare Epidemiology of America, Clinical practice guidelines for antimicrobial prophylaxis in surgery, Am J Health Syst Pharm, 2013, 70, 195-283.

3. 3）小児CKD対策委員会, 小児慢性腎臓病（小児CKD）小児の「腎機能障害の診断」と「腎機能評価」の手引き編集委員会, “小児慢性腎臓病（小児CKD）小児の「腎機能障害の診断」と「腎機能評価」の手引き”, 診断と治療社, 東京, 2019, p9.

4. 4）中蔵伊知郎, 坂倉広大, 小川吉彦, 上野裕之, 中多　泉, Meropenem投与症例における肝・腎機能障害発現への高用量投与が及ぼす影響と発現要因に関する後方視的調査, 日本化学療法学会雑誌, 2015, 63, 553-559.

5. 6）Bahk JH, Kim YH, Park HY, Min HK, Kim SI, Ha KY, Incidence and Risk Factors of Gastrointestinal and Hepatobiliary Complications after Spinal Fusion Surgery: a Retrospective Cohort Study, J Korean Med Sci, 2020, 35, e345. doi: 10.3346/jkms.2020.35.e345.